Chapter 3: Recognition and Response – Study Notes

Receptor-Ligand Interactions

  • Common features of receptor-ligand interactions
    • Binding is achieved via multiple noncovalent bonds.
    • Individual bonds may be weak, but together they yield a strong binding affinity.
    • Many such bonds between receptors and ligands provide substantial cumulative bond strength (avidity).
    • The dissociation constant, Kd, measures the strength of ligand binding: Kd=[R][L][RL].K_d = \frac{[R][L]}{[RL]}.
  • Least likely bond observed in receptor-ligand interactions
    • Covalent bonds are least likely; binding is predominantly noncovalent (e.g., hydrogen bonds, ionic bonds, van der Waals, etc.).
  • Receptor–ligand interactions may be multivalent
    • Multivalency increases avidity of the interactions.
    • An interaction can have weak affinity (per bond) but high overall avidity when multiple bonds form simultaneously.
    • Affinity refers to the strength of a single binding interaction; avidity refers to the cumulative strength of multiple interactions.
  • Ligand binding induces changes in receptors
    • Binding can cause conformational changes, dimerization or clustering, altered membrane localization, and covalent modifications.
    • Receptor alterations trigger intracellular cascades, including enzyme activation and relocalization of intracellular molecules.
  • Combinatorial protein chain usage increases receptor variability
    • Multiple protein chains can contribute to the ligand-binding site.
    • Different chain combinations recognize different ligands (e.g., variable region composition).
  • Ligand binding and signal transduction
    • Aggregation upon ligand binding can enhance binding affinity (lower effective Kd).
    • Inclusion of different protein chains can alter overall affinity.
    • Prolonged cell–cell contact relies on binding affinity; extended contact facilitates signal transduction and exchange of cytokine signals.
    • Extended binding can drive cytoskeletal reorganization.
  • Key visuals referenced (Fig. 3-1 to Fig. 3-5) summarize these concepts

Immunoglobulin and Immunoreceptor Architecture

  • Immunoglobulin-bearing immune receptors
    • Immune receptors contain immunoglobulin domains.
    • Receptors can be transmembrane, cytosolic, or secreted.
    • Immunoglobulin lacking the carboxyl terminus transmembrane segment is secreted.
  • Immunoglobulin structure features (Fig. 3-9 to Fig. 3-10)
    • Antibodies are quaternary proteins with two identical heavy chains and two identical light chains.
    • Antigen specificity arises from interactions between the light- and heavy-chain variable regions.
    • Effector activity (e.g., phagocytosis, complement fixation) is determined by the constant regions of the heavy chain.
    • Typical heavy chains: μ, γ, α, δ, ε; light chains: κ, λ.
    • Heavy- and light-chain variable regions form the antigen-binding site via their variable domains (V regions).
    • The antibody is composed of Fab (antigen-binding fragment) and Fc (constant) regions; Fab contains the antigen-binding sites; Fc mediates effector functions.
    • The heavy chain constant regions are separated into CH1, CH2, CH3; the light chain has CL; disulfide bonds link chains (S–S).
    • The CHO (carbohydrate) moieties attach to heavy-chain constant regions, influencing effector function and stability.
    • The hinge region provides flexibility between Fab and Fc portions; disulfide bonds stabilize the structure.
  • Antibody gene organization and surface presentation
    • Antibody variability is generated by V(D)J recombination (not detailed in slide, but implied by variable regions and CDRs).
  • Hypervariable regions and the CDRs
    • Three complementarity-determining regions (CDR1, CDR2, CDR3) exist in both heavy (VH) and light (VL) chains.
    • CDRs form the antibody combining site; framework regions (FRs) provide structural support for CDR folding.
  • Antibody isotypes and light-chain isotypes
    • Isotypes (defined by constant region sequences of the heavy chain): IgA (α), IgD (δ), IgE (ε), IgG (γ), IgM (μ).
    • Light-chain isotypes: κ (kappa) and λ (lambda).
    • IgG subclasses exist (e.g., subclasses of IgG consistent with additional diversity; exact subclass labels not enumerated on slides).
  • Major difference between membrane-bound and secreted BCR
    • The major difference is the hydrophobic segment of the heavy chain (membrane-anchoring region); secreted BCR (antibody) lacks this transmembrane hydrophobic segment.
  • Antibody variability and the combining site (CDRs and framework regions)
    • The six CDRs (CDR1-3 in VH and VL) form the antigen-binding site; framework regions provide structural support for CDRs.

Antigen Receptor Systems

  • B-cell receptor (BCR) basics
    • A BCR contains an antibody of defined specificity (membrane-bound form of the BCR).
    • The BCR complex includes signaling modules Igα and Igβ that transduce signals through immunoreceptor tyrosine-based activation motifs (ITAMs).
    • Additional signaling co-receptors: CD19, CD81, and CD21 participate in signal transduction and relay signals internally.
  • T-cell receptor (TCR) basics
    • The TCR recognizes antigen-derived peptides bound to major histocompatibility complex (MHC) molecules on antigen-presenting cells (APCs).
    • Peptide sources can be endogenous or exogenous (processed by the cell or taken up by APCs).
    • TCR subunits: two chains, α and β (two types: αβ and γδ); each chain has constant and variable regions; the variable regions contain three CDRs forming a peptide-specific binding site; the constant regions include transmembrane segments.
    • TCR coreceptors: CD4 and CD8 co-receptors define helper versus cytotoxic T-cell functions and increase peptide-binding avidity.
  • Comparison and co-receptor roles (CD4, CD8, CD28, etc.)
    • CD28 on T cells interacts with CD80/CD86 on APCs to fully activate naive T cells (co-stimulation).
    • CD3 associates with TCR and contains ITAMs to transmit activation signals.
    • BCR signaling includes Igα/Igβ with ITAMs, and coreceptors CD19, CD81, CD21 help relay signals.

Immunoglobulins: Antibody Isotypes, Subclasses, and Receptors

  • Antibody isotypes and light-chain isotypes (concepts from Fig. 3-12 and related slides)
    • Isotypes defined by heavy-chain constant regions: IgA (α), IgD (δ), IgE (ε), IgG (γ), IgM (μ).
    • Light-chain isotypes: κ and λ.
    • Subclasses exist for IgG (diversity in effector function and distribution).
  • Antibody structure and functional domains
    • Fab region houses the antigen-binding sites (V regions and CDRs).
    • Fc region mediates effector functions (binding to complement, Fc receptors on effector cells).
    • The hinge region provides flexibility; disulfide bonds link heavy and light chains.
  • Antigen-binding site composition
    • The variable regions (VH and VL) contain CDRs that determine antigen specificity.
    • The variable domains combine to form the antigen-binding site; sequence diversity in CDRs drives recognition breadth.
  • Antibody mechanisms of action
    • Effector activities (e.g., opsonization, complement activation) are mediated by interactions of the Fc region with effector molecules and receptors.

Pattern Recognition Receptors (PRRs) and PAMPs

  • Antigen receptors and PAMPs

    • Pathogen-Associated Molecular Patterns (PAMPs) are motifs recurring on bacteria, fungi, yeasts, parasites.
    • Receptors for PAMPs (Pattern-recognition receptors, PRRs) detect these motifs and are not clonally diverse; they are expressed in the same cell types across cells.
    • PRRs can be membrane-bound or intracellular.

  • Pattern-recognition receptor families (Table 3-2)

    • TLR (Toll-like receptor): localization at plasma membrane and endosomes/lysosomes; ligands include microbial carbohydrates, lipoproteins, fungal mannans, bacterial flagellin, viral RNA, etc.; functions include production of antimicrobials, antivirals, cytokines; inflammation.
    • CLR (C-type lectin receptor): plasma membrane; ligands include carbohydrate components of fungi, mycobacteria, viruses, parasites, and some allergens; functions include phagocytosis and antimicrobial/cytokine production; inflammation.
    • RLR (RIG-I-like receptor): cytosol; ligands viral RNA; function: production of interferons and cytokines.
    • NLR (NOD-like receptor): cytosol; ligands fragments of intracellular or extracellular bacterial cell-wall peptidoglycans; function: production of antimicrobials and cytokines; inflammation.
    • ALR (Absent-in-melanoma-like receptor): cytosol and nucleus; ligands viral and bacterial DNA; function: production of interferons and cytokines.
    • cGAS/STING: cGAS detects viral/bacterial DNA in the cytosol; STING transmits signal; function: production of interferons; proinflammatory responses.

  • Pattern-recognition receptor function and distribution

    • Receptors may be found on plasma membranes, cytosol, endosomes, lysosomes.
    • Recognition is broad for shared motifs; receptors are not clonally distributed but expressed broadly among the same cell types.

  • Matching activity (conceptual): Pattern receptor-to-description matching exercise (Table 3-2 matches students with descriptions)

Cytokines and Chemokines: Signals for Immune Communication

  • Definition and basic properties
    • A cytokine is a signal that instructs a cell to change its metabolic or proliferative state.
    • Cytokine signaling typically occurs via ligand binding to a complementary cell-bound receptor, producing noncovalent but high-affinity interactions.
    • Cytokine signaling often changes transcriptional programs in target cells.
  • General properties of cytokines and chemokines (Table/Slides)
    • Endocrine: released into bloodstream to affect distant cells.
    • Paracrine: affect nearby cells.
    • Autocrine: act on the same cell that released them.
    • Chemokines are a subset that directs leukocyte migration (chemoattractants).
  • Key features of cytokine action
    • Pleiotropy: a cytokine can have multiple different effects on different target cells.
    • Redundancy: two or more cytokines can mediate similar effects on the same target.
    • Synergy: combined activity of two cytokines exceeds the sum of their separate effects.
    • Antagonism: one cytokine inhibits the action of another.
    • Cascade induction: one cytokine stimulates target cells to produce additional cytokines.
  • Major cytokine families (Table 3-3)
    • IL-1 family: includes IL-1α, IL-1β, IL-1Ra, IL-18, IL-33; proinflammatory mediators; first non-interferon cytokines identified; promote inflammation.
    • Class 1 (hemtopoietin) family: includes IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-12, IL-13, IL-15, IL-21, IL-23, GM-CSF, G-CSF, and related; diverse actions; typically share subunit components.
    • Class 2 (interferon) family: Type I IFNs (IFN-α, IFN-β, etc.), Type II IFN (IFN-γ), Type III IFN (IFN-λ); roles in antiviral responses and modulation of adaptive immunity.
    • TNF family: TNF-α, TNF-β (lymphotoxin-α), and membrane-bound members (e.g., CD40L, FasL, BAFF, APRIL, LT-β); diverse roles in development, effector function, and homeostasis; often soluble or membrane-bound.
    • IL-17 family: IL-17A through IL-17F; proinflammatory, often at innate–adaptive immunity interface; receptors commonly IL-17RA/RC; exist as homodimers.
    • Chemokines: small chemoattractant proteins; direct leukocyte migration; receptors are GPCRs.
  • IL-1 family specifics (Fig. 3-19)
    • IL-1 cytokines promote inflammation; early responders from macrophages/dendritic cells; local effects on capillary permeability and leukocyte recruitment; systemic signaling to liver to produce acute phase proteins; can activate adaptive responses.
  • Class 1 cytokine subunit sharing and receptor subfamilies (Table 3-4)
    • Common subunits: γc (shared by IL-2, IL-4, IL-7, IL-9, IL-15, IL-21, IL-12), βc (IL-3, IL-5, GM-CSF), gp130 (IL-6, IL-11, LIF, OSM, CNTF, IL-27).
  • Class 2 interferons and their subtypes
    • Type I: IFN-α and IFN-β; antiviral effects; secreted by macrophages and dendritic cells; induce ribonucleases and reduce protein synthesis.
    • Type II: IFN-γ; dimer produced by activated T and NK cells; strong modulator of adaptive immunity.
    • Type III: IFN-λ; secreted by plasmacytoid dendritic cells; modulates viral replication and host cell proliferation.
  • TNF family details
    • TNF-α: proinflammatory; produced by activated macrophages and other cells.
    • TNF-β (lymphotoxin-α): produced by activated lymphocytes; signals to leukocytes and endothelial cells.
    • Membrane-bound TNF members include Lymphotoxin-β, BAFF, APRIL, CD40L, FasL; roles in lymphocyte differentiation, B-cell homeostasis, and apoptosis.
  • IL-17 family specifics (Table 3-5 and Fig. 3-22)
    • Members are proinflammatory; receptors on neutrophils, keratinocytes, and other nonlymphoid cells; function at the innate–adaptive interface; mostly homodimers; monomer sizes range ~17.3–22.8 kDa.
  • Chemokines and receptors
    • Chemokine receptors are GPCRs that signal via G proteins; many receptors bind multiple chemokines and vice versa.
    • Chemokines direct leukocyte migration and coordinate movement to tissues.

Signal Transduction Pathways in Lymphocytes

  • Receptors and signaling: overview (Fig. 3-24, 3-25, 3-26; 8-part sequence)
    • Signals are initiated by antigen engagement with receptors and/or co-receptors.
    • Receptor clustering and lipid rafts facilitate signaling; antigen-mediated clustering initiates signaling in B and T cells; dimerization and multimerization occur; clustered receptors localize to lipid rafts.
  • Early phosphorylation events
    • Tyrosine phosphorylation is an early step in many signaling pathways.
    • CD3 (T cells) and Igα/β (B cells) are phosphorylated on ITAMs (immunoreceptor tyrosine-based activation motifs).
    • Phosphorylated tyrosines serve as docking points for adapter proteins.
    • Src-family kinases phosphorylate ITAMs and are activated by phosphorylation.
  • Adapter proteins and second messengers
    • Adapter proteins assemble signaling complexes.
    • PIP2 breakdown by PLCγ generates DAG and IP3; IP3 increases cytoplasmic Ca2+; Ca2+ binds calmodulin and calcineurin, which activate transcription factors such as NFAT.
    • DAG activates protein kinase C (PKC) and contributes to NF-κB activation via IκB phosphorylation and degradation.
  • Ras/MAP kinase cascade
    • Ras, a small GTPase, cycles between GDP- and GTP-bound forms; GEFs promote the exchange (GDP→GTP).
    • Active Ras triggers the MAP kinase cascade (Raf → MEK → ERK).
    • ERK enters the nucleus and phosphorylates Fos; Fos forms a dimer with phosphorylated Jun to create the transcription factor AP-1, which promotes IL-2 gene transcription.
  • NF-κB activation pathway
    • PKC activation leads to IκB phosphorylation and degradation, freeing NF-κB to translocate into the nucleus and enhance transcription.
    • DAG and PKC activate IKK complexes; IκB is ubiquitinated and destroyed, enabling NF-κB to drive gene expression.
  • Integrated signaling and gene activation
    • Simultaneous signals through multiple receptors are integrated at the nuclear level to produce a coordinated transcriptional response (AP-1, NF-κB, NFAT).

Receptors, Signaling, and Immune Responses: Integrative View

  • Antigen signaling and immune cell responses
    • Antigen signaling coordinates dendritic cell localization, macrophage and neutrophil phagolysosome activity and cytokine production.
    • Dendritic cells present antigen peptides on MHC class I and II to activate CD8+ cytotoxic T cells and CD4+ helper T cells, respectively.
    • Cytoplasmic proteasomes process antigens into peptides for MHC presentation.
    • Dendritic cells can secrete cytokines in response to antigen signaling to shape the adaptive response.
  • Summary points for signaling and activation
    • Signal transduction is complex but shares common themes: receptor engagement, clustering, phosphorylation, adapter protein assembly, second messengers, and transcriptional changes.
    • B and T lymphocytes use similar signaling architectures once signaling is underway, but differences lie in antigen receptors and early membrane events that configure specific outcomes.

Activity-Based Concept Maps and Practice

  • Concept maps help relate terms within Chapter 3
    • Activity 1: Cytokines and chemokines — terms to connect include Cytokines, Chemokines, Cytokine receptors, Chemoattractants, Pleiotropy, Redundancy, Antagonism, Synergy, Cascade induction.
    • Activity 2: Antigen-pathogen receptors — terms include Antigens, PRRs, BCRs, TCRs, Kd, Multivalency, Avidity, Affinity, PAMPs, Lipid rafts.
    • Activity 3: BCR — terms include BCR, Variable region, Constant region, CDRs, Light chain (κ or λ), Heavy chain (μ, γ, δ, α, ε), Isotypes, Classes, Antibodies, IgM, IgE, IgD, IgA, IgG.
  • Solutions involve pairwise discussion on how concept maps might differ between individuals, reinforcing understanding of relationships rather than exact mappings.

Connections to Foundational Principles and Real-World Relevance

  • Multivalency and avidity concepts underpin many immune interactions, including antibody binding to multivalent antigens and immune synapse stability.
  • Receptor clustering and lipid rafts illustrate how spatial organization of receptors in the plasma membrane modulates signaling strength and duration.
  • ITAM-based signaling and the cascade architecture (Ca2+ signaling, Ras-MAP, PKC/NF-κB, AP-1) are foundational principles shared across many cell signaling systems, not only in immunology.
  • The balance of cytokine actions (pleiotropy, redundancy, synergy, antagonism, cascade induction) explains the complexity and fine-tuning of immune responses and informs therapeutic strategies targeting cytokines (e.g., monoclonal antibodies, cytokine inhibitors).
  • PRRs and PAMPs highlight how innate recognition shapes downstream adaptive responses, bridging innate and adaptive immunity and informing vaccine adjuvant design and antimicrobial strategies.

Key Symbols and Formulas to Remember

  • Dissociation constant and binding strength
    • Kd=[R][L][RL]K_d = \frac{[R][L]}{[RL]}
  • ITAM motif (classic receptor signaling motif)
    • ITAM consensus: Y x x [L/I] x6−8 Y x x [L/I]Y\,x\,x\,\text{[L/I]}\,x^{6-8}\,Y\,x\,x\,\text{[L/I]}
  • Ras-MAP kinase cascade (simplified flow)
    • Ras-GDP --GEF--> Ras-GTP --activates--> RAF --MEK--> ERK --nuclear TFs (AP-1: Fos/Jun)--> target gene transcription
  • PLCγ pathway and Ca2+ signaling
    • PIP2 --PLCγ--> IP3 + DAG; IP3 releases Ca^{2+} from endoplasmic reticulum; Ca^{2+} binds calmodulin and activates calcineurin; calcineurin dephosphorylates NFAT and promotes transcription.

Note: Figures referenced (e.g., Figs. 3-1 through 3-27) illustrate these concepts, but are not reproduced here. The notes above summarize the content described in each slide and connect concepts across receptor–ligand interactions, antibody biology, PRRs, cytokines, and signaling pathways.